Acquire September 2018 - Glycomark September 2018 - Glycomark

News

Visit GlycoMark at the NJ AACE for complementary GlycoMark testing!


Posted on September 28, 2018 by


Join us while exhibits are open on October 6 to have your blood drawn by Accu Reference Medical Lab, a preferred GlycoMark lab partner and proud sponsor of conference attendee testing. The GlycoMark test is the only FDA-cleared blood test specific to detecting recent hyperglycemia and hyperglycemic excursions (occurring in the fasting state, postprandial, or both).…
Read More

GlycoMark®, Inc. Announces Partnership with Premier Medical Laboratory Services to Expand Diabetes Test Menu


Posted on September 25, 2018 by


New York, NY.  Sept. 25th, 2018 – GlycoMark®, Inc. has announced a partnership with Premier Medical Laboratory Services (PMLS) to increase the availability of the GlycoMark test, the only FDA-cleared blood test specific to detecting recent hyperglycemia and hyperglycemic excursions in patients with diabetes. With the partnership, PMLS will promote and offer the GlycoMark test…
Read More

Visit GlycoMark at the Cardiometabolic Risk Summit


Posted on September 11, 2018 by


Visit GlycoMark’s booth the Cardiometabolic Risk Summit in San Antonio, TX on September 14-15, 2018, to learn more about the GlycoMark test. This test is the only FDA-cleared blood test specific to detecting recent hyperglycemia and hyperglycemic excursions (occurring in the fasting state, postprandial, or both).  To schedule a meeting with one of our experts,…
Read More